Subject(s)
Biomedical Research , COVID-19 , Coronavirus , Financing, Organized , National Institutes of Health (U.S.) , Humans , Biomedical Research/economics , Biomedical Research/legislation & jurisprudence , Biomedical Research/trends , COVID-19/epidemiology , COVID-19/transmission , COVID-19/virology , National Institutes of Health (U.S.)/economics , National Institutes of Health (U.S.)/legislation & jurisprudence , Politics , United States , Viral Zoonoses/epidemiology , Viral Zoonoses/transmission , Viral Zoonoses/virology , AnimalsABSTRACT
Investment, collaboration, and coordination have been key.
Subject(s)
Biomedical Research , COVID-19 , Humans , Biomedical Research/economics , Biomedical Research/trends , COVID-19/prevention & control , COVID-19/therapy , National Institutes of Health (U.S.) , Investments , International Cooperation , COVID-19 Vaccines , Clinical Trials as TopicSubject(s)
Biomedical Research/organization & administration , Biomedical Research/trends , Vaccines/supply & distribution , Africa/epidemiology , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19 Vaccines/economics , COVID-19 Vaccines/supply & distribution , Developed Countries/economics , Developing Countries/economics , Drug Industry/trends , Humans , Public Sector , Research Personnel , Vaccines/economics , World Health Organization/organization & administrationSubject(s)
Biomedical Research , COVID-19 , Humans , SARS-CoV-2 , Biomedical Research/trends , ForecastingABSTRACT
Major funding effort aims to address weaknesses exposed by COVID-19 pandemic.
Subject(s)
Biomedical Research , COVID-19 , Neglected Diseases , Pandemics , Vaccines , Humans , COVID-19/prevention & control , Japan , Pandemics/prevention & control , Biomedical Research/economics , Biomedical Research/trends , Neglected Diseases/prevention & control , Neglected Diseases/virologySubject(s)
Biomedical Research , Child Health , Child , Humans , Child Health/trends , Biomedical Research/trendsSubject(s)
Biomedical Research/trends , Cost of Illness , Inventions/trends , Musculoskeletal Diseases/prevention & control , Preventive Medicine/trends , Humans , Musculoskeletal Diseases/economics , Musculoskeletal Diseases/epidemiology , Musculoskeletal Diseases/surgery , Orthopedic Procedures/instrumentation , Quality of Life , Sick Leave/economicsSubject(s)
Biomedical Research/trends , Disease Models, Animal , Publishing , Animals , Drug Discovery , Editorial Policies , Humans , Interdisciplinary Research , Phenotype , PublicationsABSTRACT
Background: Myopia is one of the most common causes of vision impairment in children and adults and has become a public health priority with its growing prevalence worldwide. This study aims to identify and evaluate the global trends in myopia research of the past century and visualize the frontiers using bibliometric analysis. Methods: The literature search was conducted on the Web of Science for myopia studies published between 1900 and 2020. Retrieved publications were analyzed in-depth by the annual publication number, prolific countries and institutions, core author and journal, and the number of citations through descriptive statistics. Collaboration networks and keywords burst were visualized by VOSviewer and CiteSpace. Myopia citation network was visualized using CitNetExplorer. Results: In total, 11,172 publications on myopia were retrieved from 1900 to 2020, with most published by the United States. Saw SM, from the National University of Singapore, contributed the most publications and citations. Investigative Ophthalmology & Visual Science was the journal with highest number of citations. Journal of Cataract and Refractive Surgery with the maximum number of publications. The top 10 cited papers mainly focused on the epidemiology of myopia. Previous research emphasized myopia-associated experimental animal models, while recent keywords include "SMILE" and "myopia control" with the stronger burst, indicating a shift of concern from etiology to therapy and coincided with the global increment of incidence. Document citation network was clustered into six groups: "prevalence and risk factors of myopia," "surgical control of myopia," "pathogenesis of myopia," "optical interventions of myopia," "myopia and glaucoma," and "pathological myopia." Conclusions: Bibliometrics analysis in this study could help scholars comprehend global trends of myopia research frontiers better. Hundred years of myopia research were clustered into six groups, among which "prevalence and risk factors of myopia" and "surgical control of myopia" were the largest groups. With the increasing prevalence of myopia, interventions of myopia control are a potential research hotspot and pressing public health issue.
Subject(s)
Biomedical Research , Myopia , Bibliometrics , Biomedical Research/trends , Humans , Myopia/epidemiology , Public HealthSubject(s)
Biomedical Research/trends , COVID-19 , Pregnancy Complications, Infectious/virology , SARS-CoV-2 , Female , Humans , PregnancySubject(s)
Betacoronavirus , Biomedical Research/trends , Coronavirus Infections , Global Health/trends , Pandemics , Pneumonia, Viral , Brazil/epidemiology , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Health Policy/trends , Humans , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , SARS-CoV-2Subject(s)
Biomedical Research/methods , COVID-19/prevention & control , Neoplasms/therapy , Patient Care/methods , Research Report , American Cancer Society/organization & administration , Biomedical Research/statistics & numerical data , Biomedical Research/trends , COVID-19/epidemiology , COVID-19/virology , Humans , Medical Oncology/methods , Medical Oncology/statistics & numerical data , Medical Oncology/trends , Neoplasms/diagnosis , Pandemics/prevention & control , Patient Care/statistics & numerical data , Patient Care/trends , SARS-CoV-2/physiology , United StatesSubject(s)
Biomedical Research/trends , COVID-19/complications , Cognitive Dysfunction/epidemiology , Fatigue/epidemiology , Uncertainty , Adolescent , Adult , COVID-19/epidemiology , COVID-19/immunology , COVID-19/therapy , COVID-19 Vaccines/administration & dosage , COVID-19 Vaccines/immunology , Child , Child, Preschool , Clinical Trials as Topic/methods , Cohort Studies , Humans , Prevalence , United Kingdom/epidemiology , Post-Acute COVID-19 SyndromeSubject(s)
Biomedical Research , Biotechnology , Internationality , Biomedical Research/trends , Biotechnology/trends , HumansABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has had worldwide repercussions for health care and research. In spring 2020, most non-COVID-19 research was halted, hindering research across the spectrum from laboratory-based experimental science to clinical research. Through the second half of 2020 and the first half of 2021, biomedical research, including cardiovascular science, only gradually restarted, with many restrictions on onsite activities, limited clinical research participation, and the challenges associated with working from home and caregiver responsibilities. Compounding these impediments, much of the global biomedical research infrastructure was redirected toward vaccine testing and deployment. This redirection of supply chains, personnel, and equipment has additionally hampered restoration of normal research activity. Transition to virtual interactions offset some of these limitations but did not adequately replace the need for scientific exchange and collaboration. Here, we outline key steps to reinvigorate biomedical research, including a call for increased support from the National Institutes of Health. We also call on academic institutions, publishers, reviewers, and supervisors to consider the impact of COVID-19 when assessing productivity, recognizing that the pandemic did not affect all equally. We identify trainees and junior investigators, especially those with caregiving roles, as most at risk of being lost from the biomedical workforce and identify steps to reduce the loss of these key investigators. Although the global pandemic highlighted the power of biomedical science to define, treat, and protect against threats to human health, significant investment in the biomedical workforce is required to maintain and promote well-being.
Subject(s)
Biomedical Research/trends , COVID-19 , Cardiology/trends , Research Design/trends , Research Personnel/trends , Advisory Committees , American Heart Association , Biomedical Research/education , Cardiology/education , Diffusion of Innovation , Education, Professional/trends , Forecasting , Humans , Public Opinion , Research Personnel/education , Time Factors , United StatesABSTRACT
The COVID-19 pandemic and subsequent lockdown had a substantial impact on normal research operations. Researchers needed to adapt their methods to engage at-home participants. One method is crowdsourcing, in which researchers use social media to recruit participants, gather data, and collect samples. We utilized this method to develop a diagnostic test for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). Participants were recruited via posts on popular social-media platforms, and enrolled via a website. Participants received and returned a mail kit containing bladder symptom surveys and a urine sample cup containing room-temperature preservative. Using this method, we collected 1254 IC/BPS and control samples in 3 months from all 50 United States. Our data demonstrate that crowdsourcing is a viable alternative to traditional research, with the ability to reach a broad patient population rapidly. Crowdsourcing is a powerful tool for at-home participation in research, particularly during the lockdown caused by the COVID-19 pandemic.